Crypto Meets Wall Street - Are You Ready?

The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.

2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores

Vishaal Sanjay
October 03, 2025

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga’s Edge Stock Rankings, showing remarkable strength and fervor over the past week.

2 Health-Tech Stocks With A Surge In Momentum

In Benzinga’s Edge Rankings, the Momentum score basically indicates the strength of a stock relative to all other stocks ranked. It considers price movements and volatility across multiple time frames, before ranking them individually as a percentile against others.

See Also: This Chinese Automaker Is Running Circles Around Tesla In 2025: Xpeng Stock Soars As EV Demand Heats Up In China

Over the past week, these two health-tech stocks have seen significant improvements in their respective momentum scores, and here's why?

1. Sophia Genetics SA

Swiss medtech company, Sophia Genetics SA (NASDAQ:SOPH), has seen its Benzinga Momentum score surge over the past week, rising from 32.45 to 81.80.

This comes following the stock’s 30% surge over the past month, after the company expanded its collaboration with AstraZeneca PLC (NASDAQ:AZN) to jointly develop an AI-powered next-generation sequencing solution targeting breast and prostate cancer.

The stock scores high on Momentum in Benzinga’s Edge Stock Rankings, with a favorable price trend in the short, medium and long terms. Click here for deeper insights into the stock, its peers and competitors.

2. DarioHealth Corp

New York-headquartered DarioHealth Corp. (NASDAQ:DRIO) makes personalized health management solutions, particularly for those suffering from chronic conditions.

The stock’s Momentum score surged from 7.69 to 59.45 within the span of a week, in line with the stock that has soared over 83% within the past month. This rally has been driven by the company’s announcement that it had formed a committee to explore a potential sale, merger or business combination.

According to Benzinga’s Edge Stock Rankings, the stock does fairly well on Momentum, with a favorable price trend in the short, medium and long terms. Click here for deeper insights into the stock, its peers and competitors.

Read More:

  • These 2 Small Regional Banks Are Turning Up The Heat: Growth Score Spikes Amid Strong Earnings

Photo courtesy: Korot Yurii on Shutterstock.com

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

America Has A New No. 1 Beer — And It's Got Bud Light DNA

When it comes to beer in the United States, there's a new bestselling brand.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz

On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Treasury chief says wars and tariffs are harming the UK's economic outlook

LIVERPOOL, England (AP) — Britain’s Treasury chief warned Monday that wars in Ukraine and the Middle East and economic headwinds sparked by U.S. have worsened the U.K.'s economic outlook since the governing Labour Party won power last year.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Meta Unveils $499 Oakley Vanguard And $799 Ray-Ban Display Smart Glasses At Connect 2025: Gene Munster Says 'Best Bang For The Buck'

Meta unveiled its $499 Oakley Vanguard and $799 Ray-Ban Display smart glasses at Connect 2025, with Gene Munster calling the Ray-Ban model the "best bang for the buck" as competition with Apple heats up.

Trump Poised To Delay TikTok Deadline Again Amid US–China Tension: 'We May Let It Die'

President Donald Trump is expected to extend the TikTok divestment deadline for a fourth time as ByteDance, valued at $330 billion with surging revenue, faces U.S.–China tensions over its prized algorithm.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Federal judge tosses Trump's $15B defamation lawsuit against New York Times

TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

The Cross-Chain Giant Set for 1,000%+ Gains - Ad

As crypto markets surge, one multi-chain financial protocol is being targeted for massive institutional investment. Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it - creating a coiled spring ready to release.

Why was Jimmy Kimmel's late-night show suspended? Here's what we know

NEW YORK (AP) — ABC has pulled off the air, indefinitely — an unprecedented move that followed backlash from affiliated broadcasters and the head of the Federal Communications Commission over the comic's remarks about last week's killing of conservative activist .

Circle November 6 - Huge Tesla News? - Ad

Tesla could be about to change forever. On November 6, insiders are warning of a "critical inflection point", which could have a dramatic impact on the stock market. Do not buy OR sell Tesla stock until you have all the facts.

Denmark leads an exercise in Greenland, with Russia in mind at a time of tensions with the US

NUUK, Greenland (AP) — Denmark is leading a military exercise with hundreds of troops from several European NATO members in Greenland, a maneuver that coincides with over the Trump administration's desire for U.S. jurisdiction over the vast Arctic territory.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Elon's $1,000,000,000,000 Payday - Ad

Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market. If his plan succeeds, this is the stock to own.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area

Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.

Small Caps Rally, Intel Rockets On Best Day Ever: What's Moving Markets Thursday?

The Russell 2000, which tracks small caps, rallied on Thursday, outpacing large-cap benchmarks as investors piled into interest-rate-sensitive stocks a day after the Federal Reserve cut rates by 25 basis points and signaled more easing ahead

Crypto Meets Wall Street - Are You Ready? - Ad

The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.

SciSparc Stock Shoots Up Over 89% After Hours: What's Going On?

SciSparc's stock surged 89.13% to $3.48 after-hours on news of a court-granted stay in its merger with AutoMax, though the stock remains down 71.87% over the past year.

Bill Gates Backs Utah Geothermal Plant As Fervo Energy Targets 500 MW Capacity At Cape Station

Bill Gates and Breakthrough Energy support Fervo Energy's Cape Station project, aiming to generate 500 MW of geothermal power.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Why Redwire Stock Is Gaining Today

Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

UK inflation remains nearly double target ahead of expected interest rate hold

LONDON (AP) — Inflation in the U.K. held steady at 3.8% in the year to August, official figures showed Wednesday, a day before the Bank of England is widely expected to keep interest rates on hold.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

FTC sues Ticketmaster, saying it forces fans to pay more for concerts and events

The Federal Trade Commission and a bipartisan group of state attorneys general sued Ticketmaster and its parent company Thursday, saying they are forcing consumers to pay more to see live events through a variety of illegal tactics.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service